文献速递儿童感染

尼加拉瓜儿童登革、基孔肯雅与寨卡18年比较:单中心前瞻性队列研究

Comparison of dengue, chikungunya, and Zika among children in Nicaragua across 18 years: a single-centre, prospective cohort study.
PubMed 文献 · Lancet Child Adolesc Health · 2025-01-01

该单中心前瞻性队列基于尼加拉瓜持续运行的儿童登革队列,纳入2006至2023年实验室确诊的1405例登革、517例基孔肯雅和522例寨卡病例,分析发病前10天临床特征。研究发现多种临床特征在三种疾病间总体、按年龄和按病日差异显著,并识别出可改善鉴别诊断的关键特征;62例无发热登革病例提示需重新考虑现行指导。

要点

  • 嗜碱性粒细胞增多、单核细胞减少、腹痛和白细胞减少最能区分登革。
  • 关节痛及无丘疹、无白细胞减少、无结膜充血最能区分基孔肯雅。
  • 全身皮疹及无发热、无头痛、无肌痛、无淋巴细胞减少最能区分寨卡。

核心结论

  • 研究大幅更新了对儿童登革、基孔肯雅和寨卡的理解,并识别出可改善鉴别诊断的多种临床特征。
  • 无发热登革病例的出现提示应重新考虑现行指导。

研究设计与样本

  • 单中心前瞻性队列研究,基于2004年8月30日在尼加拉瓜马那瓜II区启动的持续儿童登革队列研究(PDCS)。
  • 纳入2006年1月19日至2023年12月31日在健康中心就诊的实验室确诊登革、基孔肯雅和寨卡病例。
  • 评估发病前10天临床记录和实验室结果,使用广义相加模型、按日及按病的患病率估计和机器学习模型。

主要发现

  • 登革、基孔肯雅和寨卡病例的许多临床特征患病率在总体、按年龄和按病日上差异显著。

关键数值与推荐

  • 基于提升回归树模型,关节痛及无嗜碱性粒细胞增多和无白细胞减少最能区分基孔肯雅。
  • 基于提升回归树模型,嗜碱性粒细胞增多和白细胞减少最能区分登革。
  • 基于提升回归树模型,无发热最能区分寨卡。

临床怎么用

  • 儿科医生可结合嗜碱性粒细胞增多、白细胞减少、腹痛等特征优先考虑登革。
  • 关节痛伴无丘疹、无白细胞减少、无结膜充血时更支持基孔肯雅。
  • 全身皮疹伴无发热、无头痛、无肌痛、无淋巴细胞减少时更支持寨卡。
  • 对无发热但符合其他登革特征的患儿仍需警惕登革,因部分无发热登革病例可有重症预警迹象。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Dengue, chikungunya, and Zika are diseases of major human concern. Differential diagnosis of these three diseases is complicated in children and adolescents due to overlapping clinical features (signs, symptoms, and complete blood count results). Few studies have directly compared these three diseases. We aimed to use 18 years of primary care observations from a paediatric cohort to characterise the distinguishing features of dengue, chikungunya, and Zika. METHODS: This single-centre prospective cohort study was based on the ongoing Pediatric Dengue Cohort Study (PDCS), which started on Aug 30, 2004, in District II of Managua, Nicaragua. The PDCS was initiated to study dengue virus infections in children who attended the Health Center Sócrates Flores Vivas (HCSFV) for their medical needs; over the years, the PDCS expanded the age range (2 to <10 years expanded to 2 to <18 years). The PDCS also expanded eligibility criteria to include chikungunya virus and Zika virus before they entered the geographical study area in August, 2014 and January, 2016, respectively. For this study, we included laboratory confirmed cases of dengue, chikungunya, and Zika enrolled in the PDCS between Jan 19, 2006, and Dec 31, 2023, and evaluated at the HCSFV. We assessed clinical features (clinical records and laboratory results) during the first 10 days of illness using generalised additive models, day-specific and disease-specific prevalence estimates, and machine learning models. FINDINGS: We characterised 1405 dengue, 517 chikungunya, and 522 Zika cases. The median age was 10·0 years (IQR 7·0-12·7); 1165 (47·7%) cases were male and 1279 (52·3%) were female. The prevalence of many clinical features shown by dengue, chikungunya, and Zika cases differed substantially overall, by age, and by day of illness. The presence of basophilia (prevalence difference 42·3% [95% CI 37·4 to 47·0]), monocytopenia (13·0% [10·0 to 16·4]), abdominal pain (19·1% [15·7 to 22·9]), and leukopenia (41·1% [36·2 to 45·6]) best distinguished dengue; the presence of arthralgia (60·5% [56·3 to 64·2]) and absence of papular rash (-14·9% [-17·2 to -12·7]), leukopenia (-32·0% [-36·7 to -27·1]), and conjunctival injection (-4·9% [-6·6 to -3·3]) best distinguished chikungunya; and the presence of generalised rash (35·0% [30·1 to 39·7]) and absence of fever (-37·3% [-41·7 to -33·0]), headache (-36·2% [-41·1 to -31·2]), myalgia (-30·1% [-33·9 to -26·2]), and lymphocytopenia (-41·9% [-46·6 to -37·1]) best distinguished Zika. Dengue and chikungunya cases showed similar temperature dynamics during acute illness, and their mean temperatures were higher than Zika cases. 62 laboratory confirmed afebrile dengue cases, which would not be captured by any widely used international case definition, presented most similarly to afebrile Zika cases, but five (8·1%) had warning signs of dengue disease severity. Based on boosted regression tree models, the presence of arthralgia and absence of basophilia and leukopenia most distinguished chikungunya, the presence of basophilia and leukopenia most distinguished dengue, and the absence of fever most distinguished Zika. INTERPRETATIONS: These findings substantially update the understanding of dengue, chikungunya, and Zika in a paediatric population and identify various clinical features that could improve differential diagnoses. The occurrence of afebrile dengue warrants reconsideration of current guidance. FUNDING: US National Institutes of Health. TRANSLATION: For the Spanish translation of the abstract see Supplementary Materials section.

来源:Lancet Child Adolesc Health,查看原文。版权归原作者所有。

引用

  1. Carrillo FAB, Ojeda S, Sanchez N, et al. Comparison of dengue, chikungunya, and Zika among children in Nicaragua across 18 years: a single-centre, prospective cohort study. Lancet Child Adolesc Health. 2025. PMID: 40774783. doi:10.1016/S2352-4642(25)00168-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。